Acción Predictive Oncology (POAI)
Empresa que cotiza en bolsa. Aquí tienes el precio, un resumen del negocio y lo que conviene saber sobre Predictive Oncology en septiembre 2026.
Predictive Oncology Inc. is engaged in using artificial intelligence (AI) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The Company offers a suite of solutions for oncology drug development from early discovery to clinical trials.
Sobre esta acción
Predictive Oncology Inc
POAI
Precio actual
$0.98
Beneficio potencial a 12 meses
N/A
Sector
N/A
Industria
N/A
Símbolo
POAI
Capitalización de mercado
$88.23M
Beneficio potencial a 12 meses
N/A
Sector
N/A
Industria
N/A
Rendimiento del crecimiento a seis meses
Resumen del rendimiento de la acción
Calificación de los analistas
Analysts suggest keeping Predictive Oncology's stock as it shows limited growth potential.
Salud financiera
Predictive Oncology Inc is generating moderate revenue and profit margins, with a positive cash flow.
Ve más acciones descargando la app GRATIS
Solo toma 60 segundos.
¿Por qué invertir con Nemo?
Cero comisiones
Opera acciones, ETF y más sin comisiones. Conserva una mayor parte de tus ganancias.
Confiable y regulado
Parte del grupo Exinity desde 2015, con más de un millón de clientes en todo el mundo.